Werbung
Werbung
TERN
Terns Pharmaceuticals, Inc. Common Stock
35.45
USDGesponsert
-2.32
-6.14%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
35.24
-0.21
-0.60%
TERN Ergebnisberichte
Positives Überraschungsverhältnis
TERN übertreffen die 16 der letzten 20Schätzungen.
80%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.29
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+7.41%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/+20.83%
Terns Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 10. Nov. 2025, TERN reported earnings of -0.27 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 10.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an increase of 7.41% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Terns Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Terns Pharmaceuticals, Inc. Common Stock reported EPS of -$0.27, beating estimates by 10.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Terns Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 7.64%, changed from $19.12 before the earnings release to $20.58 the day after.
When is Terns Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Terns Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 13
analysts, Terns Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung